TSE:BHC Bausch Health Companies (BHC) Stock Price, News & Analysis C$7.53 -0.05 (-0.66%) As of 04/25/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesBuy This Stock About Bausch Health Companies Stock (TSE:BHC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BHC alerts:Sign Up Key Stats Today's RangeC$7.38▼C$7.5950-Day RangeC$6.01▼C$11.0652-Week RangeC$5.45▼C$13.74Volume289,086 shsAverage Volume336,120 shsMarket CapitalizationC$1.96 billionP/E RatioN/ADividend Yield0.76%Price TargetN/AConsensus RatingHold Company OverviewBausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Read More… Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter. Email Address BHC Stock News HeadlinesRaymond James Sticks to Its Hold Rating for Bausch Health Companies (BHC)April 22, 2025 | markets.businessinsider.comBausch Health Says Carl Icahn Has 34% Economic Interest In Its Outstanding SharesApril 22, 2025 | msn.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 26, 2025 | Porter & Company (Ad)Bausch Health jumps after Carl Icahn’s 34% stakeApril 22, 2025 | msn.comBausch Health price target lowered to $5 from $7 at BofAApril 21, 2025 | markets.businessinsider.comBausch Health Companies Inc (BHC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...April 21, 2025 | finance.yahoo.comBausch Health Companies Inc.: U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against NorwichApril 17, 2025 | finanznachrichten.deAnalysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Evolent Health (EVH) and Bausch Health Companies (BHC)February 21, 2025 | markets.businessinsider.comSee More Headlines BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Companies' stock was trading at C$11.62 at the beginning of the year. Since then, BHC stock has decreased by 35.2% and is now trading at C$7.53. View the best growth stocks for 2025 here. How do I buy shares of Bausch Health Companies? Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Bausch Health Companies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Meta Platforms (META), Advanced Micro Devices (AMD), Enbridge (ENB), Shopify (SHOP), NVIDIA (NVDA) and Ford Motor (F). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolTSE:BHC CIKN/A Webwww.valeant.com Phone514-744-6792FaxN/AEmployees19,900Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.68) Trailing P/E RatioN/A Forward P/E Ratio1.36 P/E Growth0.21Net IncomeC$-125,650,969.23 Net Margins-1.88% Pretax MarginN/A Return on Equity15.87% Return on Assets4.16% Debt Debt-to-Equity Ratio-1,831.94 Current Ratio1.19 Quick Ratio0.58 Sales & Book Value Annual SalesC$6.69 billion Price / Sales0.29 Cash FlowC$0.97 per share Price / Cash Flow7.76 Book ValueC($0.66) per share Price / Book-11.46Miscellaneous Outstanding Shares260,055,152Free FloatN/AMarket CapC$1.96 billion OptionableNot Optionable Beta0.77 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (TSE:BHC) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDeepSeek’s Clear and Present DangerDeepSeek — the alleged “$5.5 million” AI project — isn’t an open-source breakthrough. It’s a Trojan horse.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.